Qingchao Tang

Harbin Medical University

Papers

2

Total Citations

12

H-Index

2

About

Qingchao Tang is a pioneering colorectal surgeon whose research is reshaping the landscape of minimally invasive oncology. His primary focus lies in advancing robotic surgery for colorectal cancer, with a particular emphasis on comparing emerging domestic robotic systems against established international platforms. Tang’s landmark prospective cohort study, "Short-term outcomes of KangDuo surgical robot- versus Da Vinci surgical robot-assisted radical resection of colorectal cancer" (2025, 8 citations), provides critical evidence that China’s KD-SR-01 system is substantially equivalent to the Da Vinci platform, a finding with profound implications for surgical access and cost-effectiveness. He has also led a multicenter propensity score-matched analysis (2024, 4 citations) demonstrating the benefits of robotic natural orifice specimen extraction surgery over transabdominal extraction for early-stage rectal cancer, a technique that reduces incisions and accelerates recovery. With his work accumulating citations and influencing clinical protocols, Tang stands at the forefront of validating next-generation robotic tools and refining surgical techniques that prioritize patient outcomes. His contributions are not merely technical; they are shaping the future of affordable, high-quality cancer care worldwide.

Research Focus

Key Achievements

2
H-Index
2
Papers
12
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Short-term outcomes of KangDuo surgical robot- versus Da Vinci surgical robot-assisted radical resection of colorectal cancer: a prospective cohort study
8 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 34
🏛 Institutions: Harbin Medical University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago